MicroRNA‑495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin‑like growth factor receptor‑1

  • Authors:
    • Ying Ye
    • Juhua Zhuang
    • Guangdong Wang
    • Saifei He
    • Suiliang Zhang
    • Guoyu Wang
    • Jing Ni
    • Jiening Wang
    • Wei Xia
  • View Affiliations

  • Published online on: November 8, 2017     https://doi.org/10.3892/etm.2017.5467
  • Pages:1150-1158
Metrics: HTML 0 views | PDF 0 views
0

Abstract

Hepatocellular carcinoma (HCC) is the fifth most common malignancy and second‑most frequent cause of cancer‑associated deaths worldwide. Previously, increasing studies report that microRNAs (miRNAs/miRs) are abnormally expressed in various types of human cancers and may participate in the tumourigenesis and tumour development of HCC. miRNA‑based targeted therapy is effective against different molecular targets and may increase the sensitisation of cancer cells to therapy by several folds. Therefore, further validation of potentially important miRNAs involved in HCC initiation and progression may provide valuable insights into the treatment of patients with HCC. miR‑495 is abnormally expressed in multiple types of human cancers. However, the expression level and roles of miR‑495 in HCC have yet to be completely elucidated. In the present study, miR‑495 expression was frequently downregulated in HCC tissues and cell lines, and miR‑495 expression levels were significantly correlated with tumour size, tumor‑node‑metastasis (TNM) stage and lymph node metastasis in patients with HCC. Functional assays revealed that miR‑495 overexpression inhibited cell proliferation and invasion in HCC. Insulin‑like growth factor receptor‑1 (IGF1R) was identified as a direct target gene of miR‑495 in HCC. IGF1R was upregulated in HCC tissues and negatively correlated with miR‑495 expression level. The upregulation of IGF1R rescued the miR‑495‑induced tumour‑suppressive roles in HCC cell proliferation and invasion, and the restored miR‑495 expression inactivated the protein kinase B and extracellular regulated protein kinase signalling pathways in HCC. These results provide novel insights into the molecular mechanism underlying HCC progression, and suggest that miR‑495 may be investigated as a novel therapeutic target for patients with this disease.

Related Articles

Journal Cover

January 2018
Volume 15 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

2016 Impact Factor: 1.261
Ranked #50/128 Medicine Research and Experimental
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Ye, Y., Zhuang, J., Wang, G., He, S., Zhang, S., Wang, G. ... Xia, W. (2018). MicroRNA‑495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin‑like growth factor receptor‑1. Experimental and Therapeutic Medicine, 15, 1150-1158. https://doi.org/10.3892/etm.2017.5467
MLA
Ye, Y., Zhuang, J., Wang, G., He, S., Zhang, S., Wang, G., Ni, J., Wang, J., Xia, W."MicroRNA‑495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin‑like growth factor receptor‑1". Experimental and Therapeutic Medicine 15.1 (2018): 1150-1158.
Chicago
Ye, Y., Zhuang, J., Wang, G., He, S., Zhang, S., Wang, G., Ni, J., Wang, J., Xia, W."MicroRNA‑495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin‑like growth factor receptor‑1". Experimental and Therapeutic Medicine 15, no. 1 (2018): 1150-1158. https://doi.org/10.3892/etm.2017.5467